灵灵九生物|化工原料平台|009

主页 > 原料 > 抗肿瘤原料 >

米托蒽醌

中文名称:
米托蒽醌
中文同义词:
米托蒽醌;1,4-二羟基-5,8-双[[2-[(2-羟乙基)氨基]乙基]氨基]-9,10-蒽醌;米托蒽醌(米托恩醌、米拖蒽醌);盐酸米托蒽醌 (HPLC);米拖蒽醌;米托恩醌;1,4-二羟基-5,8-二[[2-[(2-羟基乙基)氨基]乙基]氨基]蒽-9,10-二酮;拓扑异构酶II(TOPOISOMERASE II)抑制剂(MITOXANTRONE)
英文名称:
Mitoxantrone
英文同义词:
MITOXANTRONE;1,4-dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedi;1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]-anthracene-9,10-dione;Mitoxantrone (base and/or unspecified salts);MITOXANTRONUM;1,4-Dihydroxy-5,8-bis[2-[(2-hydroxyethyl)amino]ethylamino]-9,10-anthraquinone;MitoxantroneBase;Mitoxantrone Hcl 70476-82-3 / Base
CAS号:
65271-80-9
分子式:
C22H28N4O6
分子量:
444.48
EINECS号:
1533716-785-6
相关类别:
精细化工;有机原料;小分子抑制剂,天然产物;细胞生物学试剂;生化试剂;Inhibitors;Anti-cancerimmunity;Pharmaceutical material and intermeidates;Intermediates Fine Chemicals;Pharmaceuticals
Mol文件:
65271-80-9.mol
熔点 
170-1740C
沸点 
554.47°C (rough estimate)
密度 
1.3049 (rough estimate)
折射率 
1.6500 (estimate)
储存条件 
Keep in dark place,Sealed in dry,2-8°C
酸度系数(pKa)
pKa 5.99 (Uncertain);8.13 (Uncertain)
CAS 数据库
65271-80-9(CAS DataBase Reference)
(IARC)致癌物分类
2B (Vol. 76) 2000
生物活性
Mitoxantrone是拓扑异构酶II (topoisomerase II)的抑制剂;也可抑制蛋白激酶C (PKC), IC50值为8.5 μM。
靶点
PKC 8.5 μM (IC 50 ) Topoisomerase II
PKC 8.5 μM (IC 50 )
Topoisomerase II
体外研究
Mitoxantrone inhibits PKC in a competitive manner with respect to histone H1, and its K i value is 6.3 μM and in a non-competitive manner with respect to phosphatidylserine and ATP. Treatment of B-CLL cells for 48 h with mitoxantrone (0.5 μg/mL) induces a decrease in cell viability. Mitoxantrone induces DNA fragmentation and the proteolytic cleavage of poly(ADP-ribose) polymerase (PARP), demonstrating that the cytotoxic effect of mitoxantrone is due to induction of apoptosis. Mitoxantrone shows cytotoxicity to human breast carcinoma cell lines MDA-MB-231 and MCF-7 with IC 50 values of 18 and 196 nM, respectively.
体内研究
Mitoxantrone given IP at the optimal dose (1.6 mg/kg/day; as a free base) produces a statistically significant number of 60-day survivors (curative effect) in mice with IP implanted L1210 leukemia. In SC implanted Lewis lung carcinoma, mitoxantrone and ADM administered IV also shows effective antitumor activities and produces a 60% and a 45% ILS, respectively..
化学性质 
蓝黑色结晶。熔点203-205℃。略溶于水,微溶于乙醇,不溶于氯仿和丙酮。无臭,易吸潮
用途 
蒽环类抗癌药,抗癌活性与阿霉素相似或略高,明显高于环磷酰胺、阿糖胞苷、甲氨喋呤、氟脲嘧啶、长春新碱等常用的抗癌药。临床用于乳腺癌有突出的疗效。
危险品标志 
T,T+
危险类别码 
46-61-26/27/28
安全说明 
53-36/37/39-45-22
WGK Germany 
3
RTECS号
CB5748500
价       格:请咨询卖家
CAS    号: 65271-80-9
规       格:10g/20g/100g/1kg
咨询电话:15623309010
正品保障
正规发票
闪电发货
满199包邮
详细介绍
英文名:
Mitoxantrone
外观:
纯度:
请咨询卖家
分子式:
C22H28N4O6
分子量:
444.48
中文名称:
米托蒽醌
中文同义词:
米托蒽醌;1,4-二羟基-5,8-双[[2-[(2-羟乙基)氨基]乙基]氨基]-9,10-蒽醌;米托蒽醌(米托恩醌、米拖蒽醌);盐酸米托蒽醌 (HPLC);米拖蒽醌;米托恩醌;1,4-二羟基-5,8-二[[2-[(2-羟基乙基)氨基]乙基]氨基]蒽-9,10-二酮;拓扑异构酶II(TOPOISOMERASE II)抑制剂(MITOXANTRONE)
英文名称:
Mitoxantrone
英文同义词:
MITOXANTRONE;1,4-dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedi;1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]-anthracene-9,10-dione;Mitoxantrone (base and/or unspecified salts);MITOXANTRONUM;1,4-Dihydroxy-5,8-bis[2-[(2-hydroxyethyl)amino]ethylamino]-9,10-anthraquinone;MitoxantroneBase;Mitoxantrone Hcl 70476-82-3 / Base
CAS号:
65271-80-9
分子式:
C22H28N4O6
分子量:
444.48
EINECS号:
1533716-785-6
相关类别:
精细化工;有机原料;小分子抑制剂,天然产物;细胞生物学试剂;生化试剂;Inhibitors;Anti-cancerimmunity;Pharmaceutical material and intermeidates;Intermediates Fine Chemicals;Pharmaceuticals
Mol文件:
65271-80-9.mol
熔点 
170-1740C
沸点 
554.47°C (rough estimate)
密度 
1.3049 (rough estimate)
折射率 
1.6500 (estimate)
储存条件 
Keep in dark place,Sealed in dry,2-8°C
酸度系数(pKa)
pKa 5.99 (Uncertain);8.13 (Uncertain)
CAS 数据库
65271-80-9(CAS DataBase Reference)
(IARC)致癌物分类
2B (Vol. 76) 2000
生物活性
Mitoxantrone是拓扑异构酶II (topoisomerase II)的抑制剂;也可抑制蛋白激酶C (PKC), IC50值为8.5 μM。
靶点
PKC 8.5 μM (IC 50 ) Topoisomerase II
PKC 8.5 μM (IC 50 )
Topoisomerase II
体外研究
Mitoxantrone inhibits PKC in a competitive manner with respect to histone H1, and its K i value is 6.3 μM and in a non-competitive manner with respect to phosphatidylserine and ATP. Treatment of B-CLL cells for 48 h with mitoxantrone (0.5 μg/mL) induces a decrease in cell viability. Mitoxantrone induces DNA fragmentation and the proteolytic cleavage of poly(ADP-ribose) polymerase (PARP), demonstrating that the cytotoxic effect of mitoxantrone is due to induction of apoptosis. Mitoxantrone shows cytotoxicity to human breast carcinoma cell lines MDA-MB-231 and MCF-7 with IC 50 values of 18 and 196 nM, respectively.
体内研究
Mitoxantrone given IP at the optimal dose (1.6 mg/kg/day; as a free base) produces a statistically significant number of 60-day survivors (curative effect) in mice with IP implanted L1210 leukemia. In SC implanted Lewis lung carcinoma, mitoxantrone and ADM administered IV also shows effective antitumor activities and produces a 60% and a 45% ILS, respectively..
化学性质 
蓝黑色结晶。熔点203-205℃。略溶于水,微溶于乙醇,不溶于氯仿和丙酮。无臭,易吸潮
用途 
蒽环类抗癌药,抗癌活性与阿霉素相似或略高,明显高于环磷酰胺、阿糖胞苷、甲氨喋呤、氟脲嘧啶、长春新碱等常用的抗癌药。临床用于乳腺癌有突出的疗效。
危险品标志 
T,T+
危险类别码 
46-61-26/27/28
安全说明 
53-36/37/39-45-22
WGK Germany 
3
RTECS号
CB5748500
优质服务
客服电话 1562309010
正品保障 正品保障  提供发票
急速物流 现货闪电  当时发货
售后无忧 不满意退货